Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3970393013 | Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3970394019 | Bempedoic acid 180 mg and ezetimibe 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ezetimibe (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ezetimibe (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 10 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Bempedoic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Bempedoic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 180 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Bempedoic acid and ezetimibe only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR